Bruno Filoche-Romme

This inventor holds 16 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 9 EPO patents. Top assignees: Sanofi, Aventis Pharma S.a., Ucbbiopharma Srl. Active years: 2009-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bruno Filoche-Romme. Retrieved from https://idiyas.com/inventor/bruno-filoche-romme

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 16 (Patent Applications = 5)

% Patents Active = 81.3

CIPO Patents = 1 (Patent Applications = 4)

EPO Patents = 9 (Patent Applications = 7)

Average Co-Inventor Count = 10.3

ph-index = 5

Forward Citations = 55(Granted Patents)

Location History:

Creteil, FR (2009 - 2012)
Paris, FR (2014 - 2024)

Company Filing History:

where one patent can have more than one assignee

Years Active: 2009-2024

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11912721 - Fused pentacyclic imidazole derivatives (2024-02-27),

2. 11739100 - 2,3-dihydro-1h-imidazo{1,2-a}pyrimidin-5-one and this 1,2,3,4-tetrahydropyrimido{1,2-a}pyrimidin-6-one derivatives comprising a substituted morpholine, preparation thereof and pharmaceutical use thereof (2023-08-29),

3. 11214541 - Substituted 6,7-dihydro-5H-benzo[7]annulene compounds, processes for their preparation and therapeutic uses thereof (2022-01-04),

4. 11149031 - Substituted N-(3-fluoropropyl)-pyrrolidine compounds, processes for their preparation and therapeutic uses thereof (2021-10-19),

5. 10906919 - Fused pentacyclic imidazole derivatives (2021-02-02),

6. 10570090 - Substituted 6,7-dihydro-5H-benzo[7]annulene compounds, processes for their preparation and therapeutic uses thereof (2020-02-25),

7. 10253043 - 2,3-dihydro-1H-imidazo{1,2-a}pyrimidin-5-one and this 1,2,3,4-tetrahydropyrimido{1,2-a}pyrimidin-6-one derivatives comprising a substituted morpholine, preparation thereof and pharmaceutical use thereof (2019-04-09),

8. 10202405 - Fused pentacyclic imidazole derivatives (2019-02-12),

9. 9714221 - Substituted 6,7-dihydro-5H-benzo[7]annulene compounds, processes for their preparation and therapeutic uses thereof (2017-07-25),

10. 9321790 - Pyrimidinone derivatives as antimalarial agents (2016-04-26),

11. 8846670 - 1,2,3,4-tetrahydro-pyrimido(1,2-a)pyrimidin-6-one derivatives, preparation thereof, and pharmaceutical use thereof (2014-09-30),

12. 8828997 - 2,3-dihydro-1H-imidazo(1,2-a)pyrimidin-5-one derivatives, preparation thereof, and pharmaceutical use thereof (2014-09-09),

13. 8163768 - 1,4-dihydropyridine-fused heterocycles, process for preparing the same, use and compositions containing them (2012-04-24),

14. 7968566 - Pyrrolo(2,3-b) pyridine derivatives, the preparation and the pharmaceutical use thereof in the form of kinase inhibitors (2011-06-28),

15. 7517902 - Substituted indazoles, compositions containing the same, and the preparation and use thereof (2009-04-14),

Title: The Innovative Contributions of Bruno Filoche-Romme

Introduction

Bruno Filoche-Romme is a prominent inventor based in Paris, France. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative patents. With a total of 16 patents to his name, his work focuses on developing novel compounds that have the potential to treat various human ailments.

Latest Patents

Among his latest patents, Filoche-Romme has developed a series of fused pentacyclic imidazole derivatives. These compounds serve as potent modulators of human TNFa activity, which can be beneficial in treating autoimmune and inflammatory disorders, neurological and neurodegenerative disorders, pain and nociceptive disorders, cardiovascular disorders, metabolic disorders, ocular disorders, and oncological disorders. One notable invention involves 6, 7-dihydro-7, 14-methanobenzimidazo[1, 2-b][2,5]benzodiazocin-5(14H)-one derivatives and their analogs. Additionally, he has worked on 2,3-dihydro-1h-imidazo{1,2-a}pyrimidin-5-one and 1,2,3,4-tetrahydropyrimido{1,2-a}pyrimidin-6-one derivatives, which include substituted morpholines and their pharmaceutical applications.

Career Highlights

Filoche-Romme has had a distinguished career, working with notable companies such as Sanofi and Aventis Pharma S.A. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the pharmaceutical industry.

Collaborations

Throughout his career, Filoche-Romme has collaborated with esteemed colleagues, including Laurent Schio and Maurice Brollo. These partnerships have fostered an environment of innovation and have led to the development of impactful pharmaceutical solutions.

Conclusion

Bruno Filoche-Romme's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for advancements in the treatment of various medical conditions.

Profile summary based on public USPTO records.